4
Changes in Ownership
Contineum Therapeutics, Inc. Filed Acc 0001437749-24-035887
Chief Scientific Officer sold 6,190 shares at an average $16.38 ($101,421)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lorrain Daniel S. · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-18 | Sale : show line 1 in the form 10b5-1 | −6,091 | $16.37 | $99,733 | 169,671 | D |
| 2024-11-18 | Sale : show line 2 in the form 10b5-1 | −99 | $17.05 | $1,688 | 169,572 | D |
| Open-market sales · 6,190 sh · avg $16.38 · $101,421 | ||||||
Loading xslF345X05/rdgdoc.xml…